Jonathan Robbins
InvestorInvestor at Foresite Capital
Boston, Massachusetts
Writes $2M – $75M checks · typically $38.5M
Experience
- Blackbird LaboratoriesVenture Partnercurrent2025 — present
- Foresite CapitalSenior Director2024 — 2025
- Foresite CapitalDirector2023 — 2024
- Foresite LabsDirector2023 — 2024
- Brigham and Women's HospitalAssociate Physician, Infectious Diseases2016 — 2017
- Brigham and Women's HospitalFellow in Infectious Diseases2013 — 2016
- Brigham and Women's HospitalResident in Internal Medicine2011 — 2013
- Harvard Medical SchoolInstructor in Medicine2016 — 2017
- Harvard Medical SchoolClinical Fellow2011 — 2016
- Boston Children's HospitalResearch Fellow2014 — 2017
Education
- The Rockefeller UniversityDoctor of Philosophy (PhD)
- Cornell UniversityDoctor of Medicine (M.D.)
- University of PennsylvaniaBachelor of Arts (B.A.)
Skills & more
ImmunologyClinical DevelopmentMedical MonitoringTranslational MedicineClinical TrialsDrug DevelopmentClinical ResearchMedicineGood Clinical Practice (GCP)Internal MedicineGeneticsInfectious Diseases
+12 more
NeuroscienceHealthcareClinical MonitoringCross-functional Team LeadershipTranslational ResearchDigital HealthClinical Study DesignClinical PharmacologyPeople ManagementTeam LeadershipMalariaMolecular Genetics- Board Certification in Infectious Diseases — American Board of Internal Medicine
- Board Certification in Internal Medicine — American Board of Internal Medicine
From Jonathan's professional profile.
Colleagues at Foresite Capital
Alex M. Azar II
Advisor at Foresite Capital
Alisa Mall
Partner at Foresite Capital
Amelia Stoj
CCO and Assistant General Counsel at Foresite Capital
Cindy Xiong
Investor at Foresite Capital
Collin Yang-Wong
Principal at Foresite Capital
Cynthia Carpenter
Executive Associate at Foresite Capital
Darren Haggerty
Operations Investment Analyst at Foresite Capital
Deepak Atri
Principal at Foresite Capital
Frequently asked questions
- Where does Jonathan Robbins work?
- Jonathan Robbins is Investor at Foresite Capital.
- What check size does Jonathan Robbins write?
- Jonathan Robbins typically writes checks of $2M – $75M.
Same school
Also attended The Rockefeller University9
David KaufmanInvestor at Third Rock VenturesAdam ZongEntrepreneur-In-Residence at The Innovation SpaceAlejo ChornyPrincipal Investment at Criteria Bio VenturesTommy BroudyOperating Partner, Bridgewest Group at Bridgewest VenturesTim GardnerVenture Partner at PsyMed VenturesLuca ParolariSenior Associate at DCVC (Data Collective)
+ 3 more
Also attended Cornell University703
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder CollectiveAlexandra FarmerPrincipal at Intel Capital, North America
+ 697 more
Also attended University of Pennsylvania765
Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark Capital
+ 759 more
Shared employers
Also worked at Blackbird Laboratories1
Also worked at Foresite Capital24
Victoria LewisVenture Professional at Medical Excellence CapitalChristine AylwardFounder & Managing Partner at Magnetic VenturesKunaal PatelInvestor at Acrew CapitalAustin Nalen SproleDirector at Wittington VenturesDeepak AtriPrincipal at Foresite CapitalLuke BagaasonDirector, Portfolio Valuation at Foresite Capital
+ 18 more
Also worked at Foresite Labs6
Also worked at Brigham and Women's Hospital47
Anthony PhilippakisInvestor at GV (Google Ventures)Nasra MohamedInvestor at Third Rock VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpDavid Rosenthal, MDVenture Partner at AlleyCorpChristiana BardonManaging Partner of MPM BioImpact, leading the firm's public market investingGary GottliebExecutive Partner at Flare Capital Partners
+ 41 more































)














